HCMT
HALO icon

Highland Capital Management (Tennessee)’s Halozyme HALO Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,041
Closed -$972K – 430
2026
Q1 		$972K Buy
+15,041
New +$1.06M 0.05% 239

Other funds holding HALO

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

Highland Capital Management (Tennessee)'s HALO Position: Q2 2026 in Review

Highland Capital Management (Tennessee) sold out of Halozyme (HALO) in Q2 2026, closing a stake of 15,041 shares — an estimated $972K sold.

Highland Capital Management (Tennessee) first reported a position in HALO in Q1 2026 and held it in 1 quarter. The position peaked at $972K in Q1 2026. 289 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Highland Capital Management (Tennessee) reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 15,041 Halozyme shares in Q2 2026, an estimated $972K.
  • Highland Capital Management (Tennessee) first reported a position in Halozyme in Q1 2026 and held it in 1 quarter.
  • Highland Capital Management (Tennessee)'s Halozyme position peaked at $972K in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.